TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.

Siamak Daneshmand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.